Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Careen K. Tang"'
Autor:
Terrance Grant Johns, Haizhong Feng, Careen K Tang, Ronald L. Hamilton, Tim R. Fenton, Tao Cheng, Shi Yuan Cheng, Jann N. Sarkaria, Frank B. Furnari, Yanxin Li, Michael J. Jarzynka, Webster K. Cavenee, Susan Keezer, Kristiina Vuori, Ryo Nishikawa, Bo Hu
Publikováno v:
Proceedings of the National Academy of Sciences. 109:3018-3023
Glioblastoma, the most common primary malignant cancer of the brain, is characterized by rapid tumor growth and infiltration of tumor cells throughout the brain. These traits cause glioblastomas to be highly resistant to current therapies with a resu
Publikováno v:
Cancer Letters. 306:43-51
Our previous report has shown that the constitutively activated EGFR variant, EGFRvIII, up-regulates the pro-metastatic chemokine receptor CXCR4 in breast cancer cells. Here we evaluated the biological effect and cell signaling effects of silencing C
Autor:
Careen K. Tang, David S. Salomon, Tomoko Fukuda, Takayuki Otani, Tadahiro Nagaoka, Masaharu Seno, Toshihiro Hashizume
Publikováno v:
Biotechnology Letters. 32:361-366
The extracellular domains (ECD) of epidermal growth factor receptors, ErbB1, 2, 3 and 4, were designed as soluble dimeric forms. Each ECD was fused to a short hinge region derived from IgG, such that the stable dimer could be formed with disulfide br
Publikováno v:
International Journal of Cancer. 125:1805-1813
Transducer of ErbB-2 (TOB) is a member of the TOB/Btg gene family. A role for TOB in the suppression of human tumorigenesis has been proposed, based on the observations that TOB-knockout mice spontaneously form tumors and TOB expression is lost in hu
Publikováno v:
International Journal of Cancer. 126:1850-1860
The expression of the potent, constitutively activated EGFR variant, EGFRvIII, has been linked to breast cancer metastasis, but the mechanisms of EGFRvIII and CXCR4 crosstalk, which may facilitate breast cancer invasion, have never been explored. Her
Publikováno v:
International Journal of Cancer. 125:2021-2028
The tumor specific, ligand-independent, constitutively active Epidermal Growth Factor Receptor (EGFR) variant, EGFRvIII, remains understudied in breast cancer. Here, we report that expression of EGFRvIII in the ErbB-2-overexpressing, estrogen-depende
Autor:
Pradip Roy-Burman, Surinder K. Batra, Shi Yuan Cheng, Menashe Bar-Eli, Shijie Sheng, Wen Tien Chen, Victoria L. Seewaldt, Lisa M. Coussens, Ramon Parsons, Yves A. De Clerck, Lucia R. Languino, James B. McCarthy, Srikumar Chellappan, Michael B. Cohen, Bernard E. Weissman, Anne E. Cress, Stephan Ladisch, Careen K. Tang, Dihua Yu
Publikováno v:
Cancer Biology & Therapy. 5:1588-1599
A Workshop of the Tumor Progression and Metastasis NIH Study Section In Honor of Dr. Martin L. PadarathsinghMay 31, 2006, Georgetown, Washington, DC
Autor:
Lyndsay Harris, Marina Cardillo, Mai M. Hijazi, Karen Rosenberg, Cheryl Cho, D. Yang, Careen K. Tang, Ruth Lupu, C. Perez
Publikováno v:
Breast Cancer Research and Treatment. 38:57-66
The erbB-2 receptor plays an important role in the prognosis of breast cancer and is expressed at high levels in nearly 30% of tumors in breast cancer patients. While evidence accumulates to support the relationship between erbB-2 overexpression and
Autor:
Sophie A. Lelièvre, Matthew Fred, Theodore A. Toth, Elias J. Sobrino Najul, Hua Su, Careen K. Tang, Crystal Ng
Publikováno v:
Cancer letters. 307(2)
Recent studies have shown that CXCR4 is associated with tumor metastasis. Elevated levels of CXCR4 are also detected in a high percentage of DCIS cases. The high frequency of CXCR4 expression in DCIS suggests that many DCIS cases are "primed" for inv
Publikováno v:
Cancer biologytherapy. 7(11)
Elevated levels of epidermal growth factor receptor (EGFR) have been detected in a variety of human cancers. Several reports have demonstrated that the Type III EGF receptor deletion-mutant (EGFRvIII) is frequently detected in various human cancers,